These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 28157460)
1. Anti-tuberculosis drug resistance in Ethiopia: systematic review. Weldegebreal S; Mebrahtu T Int J Tuberc Lung Dis; 2017 Jan; 21(1):18-22. PubMed ID: 28157460 [TBL] [Abstract][Full Text] [Related]
2. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118 [TBL] [Abstract][Full Text] [Related]
3. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia. Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266 [TBL] [Abstract][Full Text] [Related]
4. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017. Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia. Adane K; Ameni G; Bekele S; Abebe M; Aseffa A BMC Public Health; 2015 Jun; 15():572. PubMed ID: 26092570 [TBL] [Abstract][Full Text] [Related]
6. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336 [TBL] [Abstract][Full Text] [Related]
7. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696 [TBL] [Abstract][Full Text] [Related]
8. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231 [TBL] [Abstract][Full Text] [Related]
9. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. Lukoye D; Ssengooba W; Musisi K; Kasule GW; Cobelens FG; Joloba M; Gomez GB BMC Public Health; 2015 Mar; 15():291. PubMed ID: 25880829 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995. Liu Z; Shilkret KL; Finelli L Int J Epidemiol; 1998 Feb; 27(1):121-6. PubMed ID: 9563705 [TBL] [Abstract][Full Text] [Related]
11. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study. Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076 [TBL] [Abstract][Full Text] [Related]
12. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia. Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367 [TBL] [Abstract][Full Text] [Related]
13. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571 [TBL] [Abstract][Full Text] [Related]
14. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment. Kam KM; Yip CW Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892 [TBL] [Abstract][Full Text] [Related]
15. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece. Trakada G; Tsiamita M; Spiropoulos K Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340 [TBL] [Abstract][Full Text] [Related]
16. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation. Abate G Ethiop Med J; 2002 Jan; 40(1):79-86. PubMed ID: 12240570 [TBL] [Abstract][Full Text] [Related]
17. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117 [TBL] [Abstract][Full Text] [Related]
18. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis. Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562 [TBL] [Abstract][Full Text] [Related]
19. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997]. Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966 [TBL] [Abstract][Full Text] [Related]
20. Drug-resistant pulmonary tuberculosis in western Turkey: prevalence, clinical characteristics and treatment outcome. Surucuoglu S; Ozkutuk N; Celik P; Gazi H; Dinc G; Kurutepe S; Koroglu G; Havlucu Y; Tuncay G Ann Saudi Med; 2005; 25(4):313-8. PubMed ID: 16212125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]